HOME
FACULTY
RESEARCH
NEWS
EN
|
ES
vpn_key
LOGIN
CitationCount for TroFuse-011 study design: sacituzumab tirumotecan with or without pembrolizumab for advanced triple-negative breast cancer with PD-L1 CPS <10
Global Citation Count
Overview
Overview
has global count value
1
has global count date
October 24, 2026 1:32 AM